*  Meningococcal polysaccharide vaccine Uses, Side Effects & Warnings - Drugs.com
... includes meningococcal polysaccharide vaccine description, dosage and directions. ... meningococcal polysaccharide vaccine. Generic Name: meningococcal polysaccharide vaccine (me NIN je KOK al POL ee SAK a ride ... Meningococcal Groups A, C, Y, and W-135 Vaccine (AHFS Monograph). *Meningococcal Polysaccharide Vaccine (Groups A / C / Y and W ... Meningococcal polysaccharide vaccine is used to prevent infection caused by meningococcal bacteria. The vaccine works by ...
  https://www.drugs.com/mtm/meningococcal-polysaccharide-vaccine.html
*  High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. -...
METHODS: Twenty adults were randomly assigned to receive either a meningococcal plain-polysaccharide or conjugate vaccine; one ... Here we apply contemporary methods to describe B-cell responses to meningococcal polysaccharide and conjugate vaccines. ... RESULTS: Seven days after an initial dose of either vaccine, a gene expression signature characteristic of plasmablasts was ... Transcriptomic and flow cytometric data revealed depletion of switched memory B cells following plain-polysaccharide vaccine. ...
  https://www.paediatrics.ox.ac.uk/publications/675167
*  Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy...
Formulation of Novartis Meningococcal C Conjugate Vaccine and of the Novartis Lyophilized Meningococcal C Conjugate Vaccine ... Meningococcal Disease Meningococcal Meningitis Biological: MenC-CRM LIQ Biological: MenC-CRM ROS Biological: MenC-CRM EMV Phase ... Evaluating the Comparative Safety and Immunogenicity of Three Lots of Novartis Meningococcal C Conjugate Vaccine in Healthy ... Received any other vaccines within 30 days prior to enrollment or intent to receive any other vaccine during the study ( ...
  https://clinicaltrials.gov/ct2/show/NCT01434680?term=novartis&rank=13
*  Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for...
Novartis Vaccines and Diagnostics), a quadrivalent meningococcal conjugate vaccine, to include persons aged 2 through 55 years ... Use of Meningococcal Conjugate Vaccine in Children Aged 2 Through 10 Years ... Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for ... Vaccine 2010;28:7865--72.. * CDC. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on ...
  https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6030a3.htm?s_cid=mm6030a3_w
*  Meningococcal Vaccine Manufacturers, Suppliers & Exporters in India
Contact to Meningococcal Vaccine Exporters in India, Meningococcal Vaccine Wholesalers, Meningococcal Vaccine Distributors and ... Search Indian Meningococcal Vaccine Manufacturers and Suppliers Details - ... DTaP Combination Vaccine, Hepatitis-A Vaccine, Meningococcal Vaccine, Injectable Polio Vaccine, typhoid vaccine, rabies vaccine ... Cervical Vaccine, Influenza Vaccine, Mmr Vaccine, Oral Cholera Vaccine, Pneumococcal Conjugate Vaccine, B C G Vaccine, ...
  http://www.indianyellowpages.com/india/manufacturers/m/meningococcal-vaccine.htm
*  Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C...
... given to infants for priming followed by boosting with MenCV or a meningococcal A/C polysaccharide vaccine (MenA/C) at 12 ... this study we re-analysed the serum antibody responses from five clinical trials of serogroup C meningococcal conjugate vaccine ... immunisation with the protein-polysaccharide conjugate vaccine but not following the MenA/C plain polysaccharide vaccine. These ... after booster doses of vaccines) have been reported previously. Such correlation coefficients are widely reported by ...
  https://www.paediatrics.ox.ac.uk/publications/329054
*  A Region of the N-terminal Domain of Meningococcal Factor H Binding Protein that Elicits Bactericidal Antibody across Antigenic...
Meningococcal factor H-binding protein (fHbp) is a promising vaccine candidate that is part of two vaccines in clinical ... Meningococcal factor H-binding protein (fHbp) is a promising vaccine antigen. Previous studies described three fHbp antigenic ... Structural basis for the immunogenic properties of the meningococcal vaccine candidate LP2086. J Biol Chem. 2009 in press. [PMC ... Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines. Infect Immun. ...
  http://pubmedcentralcanada.ca/pmcc/articles/PMC2673115/
*  Meningococcal vaccine - Wikiwand
The vaccines are between 85 and 100% effective for at least two years.[1] They result in a decrease in meningitis and sepsis ... Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.[1] Different versions ... Meningococcal vaccine Connected to:. {{::readMoreArticle.title}} From Wikipedia, the free encyclopedia. .content-absolute { ... For faster navigation, this Iframe is preloading the Wikiwand page for Meningococcal vaccine. ...
  https://www.wikiwand.com/en/Meningococcal_vaccine
*  Meningococcal Vaccine
... the meningococcal vaccine is also recommended for all young people and individuals with certain medical conditions. ... The vaccines are MenACWY (meningococcal conjugate vaccine) and MPSV4 (meningococcal polysaccharide vaccine). ... Types of vaccines. This vaccine is offered in two versions in the United States. Both vaccines are quadrivalent. This means ... The meningococcal vaccine is recommended for young adults who will be living in shared spaces. It's also recommended to the ...
  https://www.healthline.com/health/vaccinations/meningococcal
*  Your Child's Immunizations: Meningococcal Vaccine
... The meningococcal vaccine protects against meningococcal disease, a serious ... your child has had a severe allergic reaction to a previous dose of meningococcal vaccine, to the DTaP vaccine, or to latex ... The meningococcal vaccine is very effective at protecting against four strains of the meningococcal bacteria. ... Why the Vaccine Is Recommended. Meningococcal disease is caused by the bacterium Neisseria meningitides. It can cause an ...
  https://www.rchsd.org/health-articles/your-childs-immunizations-meningococcal-vaccine/
*  Meningococcal vaccines for Africa - Institute of Health and Society
Meningococcal vaccines for Africa Disease caused by Neisseria meningitidis is a significant cause of morbidity and mortality in ... Protein-conjugated polysaccharide vaccines against serogroup A, C, W and Y meningococcal disease have been developed for the ... Thus, an affordable vaccine that can provide broad protection against all main serogroups causing meningococcal meningitis in ... The project aims to assess the ability of meningococcal vaccines to prevent meningitis epidemics in sub-Saharan Africa. ...
  http://www.med.uio.no/helsam/english/research/projects/meningococcal-vaccines/index.html
*  Guillain-Barré Syndrome and Menactra Meningococcal Vaccine History | Concerns | Vaccine Safety | CDC
... answers to common vaccine safety questions, information on how vaccines are monitored for safety, related research, and ... CDC's vaccine safety web site provides information about vaccine side effects, ... Where can I get more information about meningococcal vaccines?. *How can I report a case of GBS after Menactra or any vaccine? ... Where can I get more information about meningococcal vaccine?. More information is available on CDC's Meningococcal Vaccination ...
  https://www.cdc.gov/vaccinesafety/concerns/history/gbs-menactra-faqs.html
*  Meningococcal vaccine Bexsero gets FDA approval - Drug Store News
Meningococcal vaccine Bexsero gets FDA approval. BY Ryan Chavis January 26, 2015. ... "With today's approval of Bexsero, the U.S. now has two vaccines for the prevention of serogroup B meningococcal disease," said ... The Food and Drug Administration last week announced approval for Bexsero, a vaccine intended to prevent invasive meningococcal ... Meningococcal disease is a life-threatening illness caused by bacteria that can infect the bloodstream, as well as the lining ...
  https://www.drugstorenews.com/article/meningococcal-vaccine-bexsero-gets-fda-approval/?device=mobile
*  Menveo meningococcal vaccine approved for children - MPR
... meningococcal [Groups A, C, Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine) for active immunization to ... prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in children 2-10 years of ... MENVEO (meningococcal [Groups A, C, Y, W-135] oligosaccharide diphtheria CRM197 conjugate vaccine) ... oligosaccharide diphtheria CRM197 conjugate vaccine) for active immunization to prevent invasive meningococcal disease caused ...
  http://www.empr.com/news/menveo-meningococcal-vaccine-approved-for-children/article/195432/
*  Global Meningococcal Vaccines Sales Market Report 2017 - RnR Market Research
Global Meningococcal Vaccines Sales Market Report 2017 is a market research report available at US $4000 for a Single User PDF ... 2.2 Global Meningococcal Vaccines (Volume and Value) by Type. 2.2.1 Global Meningococcal Vaccines Sales and Market Share by ... 2.3 Global Meningococcal Vaccines (Volume and Value) by Region. 2.3.1 Global Meningococcal Vaccines Sales and Market Share by ... 3.3 United States Meningococcal Vaccines Sales Volume and Market Share by Type. 3.4 United States Meningococcal Vaccines Sales ...
  http://www.rnrmarketresearch.com/global-meningococcal-vaccines-sales-market-report-2017-market-report.html
*  New Meningococcal Vaccine Recs Implemented, Study Published in Morbidity and Mortality Weekly Report | BioSpace
New Meningococcal Vaccine Recs Implemented, Study Published in Morbidity and Mortality Weekly Report - read this article along ... New Meningococcal Vaccine Recs Implemented, Study Published in Morbidity and Mortality Weekly Report. Published: Jan 31, 2011 ... MedPageToday -- A new recommendation for adolescents to receive a meningococcal vaccine booster at age 16 became official this ... after evaluating evidence from case-control and serologic studies indicating that protection from the vaccine wanes within five ...
  https://www.biospace.com/article/new-meningococcal-vaccine-recs-implemented-study-published-in-b-i-morbidity-and-mortality-weekly-report-i-b-/
*  Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis. - Full Text View - ClinicalTrials.gov
The purpose of this study is to determine if the vaccine called Group B Meningococcal 44/76 MOS NOMV 5D Vaccine is safe and ... Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis.. This study has been completed. ... Meningitis, Meningococcal, Serogroup B Biological: Meningococcal 44/76 MOS NOMV 5D Phase 1 ... Received any live vaccine, experimental products or immunosuppressive therapy in the last 28 days or inactivated vaccine in the ...
  https://clinicaltrials.gov/ct2/show/NCT00248833
*  Design and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen Molecules
2006) The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum ... Pajon R, Beernink PT, Granoff DM (2012) Design of meningococcal factor h binding protein mutant vaccines that do not bind human ... 2009) Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086. J Biol Chem 284: 8738-8746 ... Design and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen Molecules. Steven ...
  http://pubmedcentralcanada.ca/pmcc/articles/PMC3486911/?lang=en-ca
*  CDC Guidelines: Use of MenB-FHbp serogroup B meningococcal vaccine | Infectious Disease Practitioner
In the United States, there are two serogroup B meningococcal (MenB) vaccines licensed for use for patients aged 10 to 25 years ... Special use of vaccines: Occupational exposure, pregnancy, & immunocompromised states. Take Quiz. Routine vaccines in children ... CDC Guidelines: Use of MenB-FHbp serogroup B meningococcal vaccine. Take Quiz. ... CDC Guidelines: Use of MenB-FHbp serogroup B meningococcal vaccine. Take Quiz. ...
  https://www.mdedge.com/idpractitioner/quiz/5173/clinical-guidelines/cdc-guidelines-use-menb-fhbp-serogroup-b-meningococcal?channel=27441
*  Meningococcal vaccines. - Oxford Vaccine Group
Through the recent availability of the meningococcal genome sequence, many new vaccine candidates are being identified and ... From being a devastating disease with a very high mortality, the possibility of eradicating invasive meningococcal disease now ... Outer membrane vesicle vaccines remain in development and further trials are anticipated. ... the major hurdle in achieving the goal of eradication is development of a safe and immunogenic vaccine against serogroup B ...
  https://www.ovg.ox.ac.uk/publications/119422
*  Meningococcal vaccine - Wikipedia
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis. Different versions are ... 2000). "Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults". Vaccine. ... This is the first meningococcal vaccine that can be given to infants as young as six weeks old. A vaccine called MenAfriVac has ... "Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine". Clin ...
  https://en.wikipedia.org/wiki/Meningococcal_vaccine
*  Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules | CMAJ
Effectiveness of meningococcal serogroup C vaccine programmes. Vaccine 2013;31:4477-86. ... Clinical experience with the meningococcal B vaccine, Bexsero(®): prospects for reducing the burden of meningococcal serogroup ... Immunogenicity of a meningococcal B vaccine during a university outbreak. N Engl J Med 2016;375:220-8. ... Group B meningococcal vaccine science and policy. J Infect 2015;71(Suppl 1):S15-20. ...
  http://www.cmaj.ca/content/189/41/E1276
*  Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Versus Mencevax™ ACWY in Healthy 18-25 Year Olds - Full Text View...
Drug Information available for: Meningococcal Vaccines Genetic and Rare Diseases Information Center resources: Meningococcal ... Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Versus Mencevax™ ACWY in Healthy 18-25 Year Olds. This study has ... Biological: GSK Biologicals' meningococcal serogroup A, C, W-135, Y tetanus toxoid conjugate investigational vaccine [GSK ... Biological: GSK Biologicals' meningococcal serogroup A, C, W-135, Y tetanus toxoid conjugate investigational vaccine [GSK ...
  https://clinicaltrials.gov/show/NCT01154088
*  Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co...
Meningococcal infections. HPV. Neisseria meningitidis. Vaccines, conjugate. tetanus. diphtheria. Meningococcal vaccines. ... Infections, Meningococcal Biological: Meningococcal vaccine GSK134612 Biological: Cervarix® Biological: Boostrix® Phase 3 ... Meningococcal Vaccines Genetic and Rare Diseases Information Center resources: Whooping Cough Meningococcal Infection ... History of meningococcal disease since birth.. *History of serious allergic reaction following any other DTP-containing vaccine ...
  https://clinicaltrials.gov/ct2/show/NCT01755689?recr=Open&cond=%22Diphtheria%22&rank=18
*  Department of Health | The Australian Standard Vaccination Schedule/National Immunisation Program 2003 to 2006
The meningococcal C conjugate vaccine (MenCCV), to be administered at age 12 months, was introduced and funded for all children ... varicella vaccine and inactivated poliomyelitis vaccine for all infants, and hepatitis A vaccine for Aboriginal and Torres ... Regarding the vaccine against Hib infection, the preferred vaccine type for Aboriginal and Torres Strait Islander infants in ... the universal varicella-zoster vaccine at 18 months of age; and. *the inactivated poliomyelitis vaccine in place of the oral ...
  http://www.health.gov.au/internet/publications/publishing.nsf/Content/cda-cdi32suppl.htm~cda-cdi32suppl-coverage.htm~cda-cdi32suppl-coverage-1.htm